Results of Hepatitis C Virus Treatment in Patients on Hemodialysis: Data From Published Meta-analyses in 2008

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2082-2084

  Casanovas Taltavull, T ^a   Baliellas Comellas, C ^a   Cruzado Garrit, J M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; INTERFERON; IRON; PEGINTERFERON; RIBAVIRIN;

ANEMIA; ARTICLE; BONE PAIN; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CYTOPENIA; DRUG WITHDRAWAL; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HEMATOLOGIC DISEASE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOPATHOLOGY; INFECTION; META ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THYROID DISEASE; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; KIDNEY FAILURE, CHRONIC; META-ANALYSIS AS TOPIC; POLYETHYLENE GLYCOLS; RENAL DIALYSIS;

EID: 68949210388     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.140     Document Type: Article

References (12)

1. Campistol J.M., Esforzado N., Barrera J.M., et al. Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment. Nephrol Dial Transplant 15 suppl 8 (2000) 68
2. Casanovas-Taltavull T., Baliellas C., Benasco C., et al. Efficacy of interferon for chronic hepatitis in kidney transplant candidates on hemodialysis: results after transplantation. Am J Gastroenterol 96 (2001) 1170
3. Pageaux G.P., Hilleret M.N., Garrigues V., et al. Treatment of hepatitis C in renal transplant recipients remains a controversial issue. Transpl Int 22 (2009) 562
4. Cruzado J.M., Casanovas-Taltavull T., Torras J., et al. Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant 3 (2003) 357
5. Koksal I. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol 21 (2006) 491
6. Sikole A., Dzekova P., Selja N., et al. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy. Ren Fail 29 (2007) 961
7. Fabrizi F., Dixit V., Messa P., et al. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials. J Viral Hepatitis 15 (2008) 79
8. Gordon C.E., Uhlig K., Lau J., et al. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis 51 (2008) 263
9. Foster G.R. Pegylated interferons: chemical and clinical differences. Aliment Pharmacol Ther 20 (2004) 825
10. Tong A., Sainsbury P., Carter S.M., et al. Patient's priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant 23 (2008) 3206
11. KDIGO Clinical Practice Guidelines for the prevention, diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 73 (2008) S1
12. Kamar N., Toupance O., Buchler M., et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 14 (2003) 2092